Pacira Biosciences Inc PCRX:NASDAQ

Last Price$38.10NASDAQ Previous Close - Last Trade as of 3:59PM ET 10/15/19

Today's Change+1.49(4.07%)
Bid (Size)$28.00 (2)
Ask (Size)$38.11 (2)
Day Low / High$36.37 - 38.52
Volume884.0 K

View Pharmaceuticals: Other IndustryPeer Comparison as of 10/15/2019


Pacira Biosciences Inc ( NASDAQ )

Price: $38.10
Change: +1.49 (4.07%)
Volume: 884.0 K
3:59PM ET 10/15/2019

Corcept Therapeutics Inc ( NASDAQ )

Price: $14.36
Change: +0.31 (2.21%)
Volume: 840.9 K
4:00PM ET 10/15/2019

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A

Ironwood Pharmaceuticals Inc ( NASDAQ )

Price: $9.04
Change: +0.01 (0.11%)
Volume: 811.1 K
3:59PM ET 10/15/2019

Supernus Pharmaceuticals Inc ( NASDAQ )

Price: $26.21
Change: +1.03 (4.07%)
Volume: 528.3 K
3:59PM ET 10/15/2019

Read more news Recent News

Sector Update: Leading Health Care Stocks Narrowly Mixed Pre-Market Wednesday
9:23AM ET 9/25/2019 MT Newswires

Top Health Care Stocks: JNJ: Flat PFE: -0.14% ABT: Flat MRK: +0.12% AMGN: Flat Leading health care stocks were narrowly mixed in pre-market trading...

MT Newswires After-Hours News Movers
5:58PM ET 9/24/2019 MT Newswires

Some of the stocks moving on news-driven events in Tuesday's after-hours include: CMTL, +15.36% SNX, +9.04% NKE, +5.54% HDS, +4.96% CTAS, +4.31% PCRX,...

Pacira Pharmaceuticals to Join S&P SmallCap 600 Index on Monday
5:48PM ET 9/24/2019 MT Newswires

Pacira Pharmaceuticals (PCRX) rose 2% in extended trade after S&P Dow Jones Indices said the stock will replace Shutterfly (SFLY) in the S&P SmallCap 600...

Earnings Projection for Pacira Biosciences in 2020 Targeted Higher
8:46PM ET 9/23/2019 MT Newswires

The 2020 forecasted earnings estimate for Pacira Biosciences Inc's (NASDAQ:PCRX, Recent Price: 37.16) for the year ending December 31, 2020 has been...

View all Commentary and Analysis

Tracking John Paulson's Paulson & Company Portfolio - Q2 2019 Update
6:16AM ET 8/30/2019 Seeking Alpha

Pacira BioSciences, Inc. (PCRX) CEO David Stack on Q2 2019 Results - Earnings Call Transcript
12:49PM ET 8/08/2019 Seeking Alpha

Biotech Stocks Getting Ready To Explode
11:38AM ET 6/17/2019 Seeking Alpha

BIIB Is For Buy-O-Gen
10:30AM ET 6/12/2019 Seeking Alpha

Company Profile

Business DescriptionPacira Biosciences, Inc. operates as a holding company, which engages in the development, commercialization, and manufacture of pharmaceutical products for use in postsurgical outcomes for acute care practitioners and their patients. Its flagship product, EXPAREL, redefines pain management after surgery as an opioid-free alternative indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia. The company was founded in December 2006 and is headquartered in Parsippany, NJ. View company web site for more details
Address5 Sylvan Way
Parsippany, New Jersey 07054
Number of Employees518
Recent SEC Filing10/10/2019SC 13G/A
Chairman, Chief Executive & Operating OfficerDavid M. Stack
PresidentMax Reinhardt
Chief Financial OfficerCharles A. Reinhart
Vice President-Research & DevelopmentVladimir Kharitonov

Company Highlights

Price Open$36.84
Previous Close$36.61
52 Week Range$34.64 - 55.00
Market Capitalization$1.6 B
Shares Outstanding41.6 M
SectorHealth Technology
IndustryPharmaceuticals: Other
Next Earnings Announcement11/07/2019

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings215.35
Earnings per Share$0.26
Beta vs. S&P 500N/A
Revenue$337.3 M
Net Profit Margin2.04%
Return on Equity2.35%

Analyst Ratings as of 08/22/2019

Consensus RecommendationConsensus Icon
Powered by Factset